Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Nov;26(11):2440-2442.
doi: 10.1002/ejhf.3449. Epub 2024 Sep 24.

Barriers to the implementation of heart failure therapy in the elderly: Let's accept the challenge!

Julian Hoevelmann  1   2 , Maurizio Volterrani  3   4 , Insa E Emrich  1
Affiliations
Free article
Editorial

Barriers to the implementation of heart failure therapy in the elderly: Let's accept the challenge!

Julian Hoevelmann et al. Eur J Heart Fail. 2024 Nov.
Free article
No abstract available

PubMed Disclaimer

References

    1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990‐2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789–1858. https://doi.org/10.1016/S0140‐6736(18)32279‐7
    1. van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016;18:242–252. https://doi.org/10.1002/ejhf.483
    1. Ziaeian B, Fonarow GC. The prevention of hospital readmissions in heart failure. Prog Cardiovasc Dis 2016;58:379–385. https://doi.org/10.1016/j.pcad.2015.09.004
    1. Inciardi RM, Staal L, Davison B, Lombardi CM, Postmus D, Felker MG, et al. Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX‐AHF‐2 trial. Eur J Heart Fail 2024;26:2431–2439. https://doi.org/10.1002/ejhf.3451
    1. Anker SD, Usman MS, Anker MS, Butler J, Bohm M, Abraham WT, et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail 2023;25:936–955. https://doi.org/10.1002/ejhf.2894

Publication types

LinkOut - more resources